Dov P. Grossman

Derek J. Fahnestock

Stephanie P. Koh

Bruce R. Genderson

Rodger D. Smith, II

Alexander S. Zolan

Ben Picozzi

Dana Kinel

Bayer AG

Janssen Pharmaceuticals Inc

Bayer Intellectual Property GmbH

Rosemont Pharmaceuticals Holdings Inc

Rosemont Pharmaceuticals Ltd

Last Docket Entry Date

Total Docket Entries

NDA submission for generic XARELTO® triggers Bayer lawsuit challenging a patent on the `once daily` dosing regimen for the blockbuster anticoagulant drug.

1:26-cv-00471 | Bayer Intellectual Property GmbH v. Rosemont Pharmaceuticals Ltd | Ex Parte

United States District of Delaware

Name	Ratings
Bayer Intellectual Property GmbH	L5A
Bayer AG	L5A
Janssen Pharmaceuticals Inc	L5A

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5A
Derek J. Fahnestock	L5A
Rodger D. Smith, II	L5A
Sidley Austin LLP	L5B
Stephanie P. Koh	L5B
Williams & Connolly LLP	L4B
Dov P. Grossman	L5A
Bruce R. Genderson	L5A
Alexander S. Zolan	L4B
Ben Picozzi	L3C
Dana Kinel	---- --

Name	Ratings
Rosemont Pharmaceuticals Ltd	---- --
Rosemont Pharmaceuticals Holdings Inc	---- --

1:26-cv-00471

Bayer IP GmbH v. Rosemont Pharma Ltd